Marjolijn N Lub-de Hooge (Marjolijn Lub-de Hooge)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Pharmaceutics

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Universitair Medisch Centrum Groningen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitair Medisch Centrum Groningen

Netherlands

Associate Professor :: Faculty of Medicine

Universitair Medisch Centrum Groningen

Netherlands

Hospital Pharmacist, deputy Head of the department of Clinical Pharmacy and Pharmacology, UMCG :: Klinische Farmacie en Farmacologie

Universitair Medisch Centrum Groningen

Netherlands

Radiopharmacist, qualified person, staff member department of Nuclear Medicine and Molecular Imaging, UMCG :: Klinische Farmacie en Farmacologie

Universitair Medisch Centrum Groningen

Netherlands

Assistant Professor :: Faculty of Medicine

Universitair Medisch Centrum Groningen

Netherlands

Hospital Pharmacist, staff member department of Clinical Pharmacy and Pharmacology, UMCG :: Klinische Farmacie en Farmacologie

Universitair Medisch Centrum Groningen Feb 01 1999 - Jun 01 2003

Netherlands

Hospital Pharmacist in training :: Klinische Farmacie en Farmacologie

Publications

Niels Westra, Daniel J Touw, Marjolijn N Lub-de Hooge, Jos Kosterink, Thijs H Oude Munnink
Pharmacokinetic Boosting of Kinase Inhibitors. Pharmaceutics 15 (4) (2023)
Niels Westra, Daniel J Touw, Marjolijn N Lub-de Hooge, Jos Kosterink, Thijs H Oude Munnink
Pharmacokinetic Boosting of Kinase Inhibitors. Pharmaceutics 15 (4) (2023)
Niels Westra, Daniel J Touw, Marjolijn N Lub-de Hooge, Jos Kosterink, Thijs H Oude Munnink
Pharmacokinetic Boosting of Kinase Inhibitors. Pharmaceutics 15 (4) (2023)
Niels Westra, Daniel J Touw, Marjolijn N Lub-de Hooge, Jos Kosterink, Thijs H Oude Munnink
Pharmacokinetic Boosting of Kinase Inhibitors. Pharmaceutics 15 (4) (2023)
Pim P van de Donk, Sjoukje F Oosting, Daan G Knapen, Anthonie J van der Wekken, Adrienne H Brouwers, Marjolijn N Lub-de Hooge, Derk-Jan A de Groot, Elisabeth Ge de Vries
Molecular imaging to support cancer immunotherapy. Journal for immunotherapy of cancer 10 (8) (2022)
Laura Kist de Ruijter, Jahlisa S Hooiveld-Noeken, Danique Giesen, Marjolijn N Lub-de Hooge, Iris C Kok, Adrienne H Brouwers, Sjoerd G Elias, Margaret T L Nguyen, Hong Lu, Jourik A Gietema, Mathilde Jalving, Derk J A de Groot, Olga Vasiljeva, Elisabeth G E de Vries
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 Probody. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Stijn Jh Waaijer, Danique Giesen, Takahiro Ishiguro, Yuji Sano, Naofumi Sugaya, Carolina P Schröder, Elisabeth Ge de Vries, Marjolijn N Lub-de Hooge
Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate. Journal for immunotherapy of cancer 8 (1) (2021)
Elly L van der Veen, Danique Giesen, Linda Pot-de Jong, Annelies Jorritsma-Smit, Elisabeth G E De Vries, Marjolijn N Lub-de Hooge
89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs. Journal for immunotherapy of cancer 8 (2) (2021)
Danique Giesen, Linda N Broer, Marjolijn N Lub-de Hooge, Irina Popova, Bruce Howng, Margaret T Nguyen, Olga Vasiljeva, Elisabeth G E de Vries, Martin Pool
Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1-Expressing Tumors Compared to Normal Murine Lymphoid Tissue. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)

Marjolijn N Lub-de Hooge.css-eqlu8i{font-size:small;padding-left:4px;} (Marjolijn Lub-de Hooge)

Publication Activity (10 Years)

Top Topics

Top Venues

Marjolijn N Lub-de Hooge (Marjolijn Lub-de Hooge)